TG Therapeutics Inc (NASDAQ:TGTX) currently has a daily average trading volume of 3.55M but it saw 2342386 shares traded in last market. With a market cap of 3.58B USD, the company’s current market price of $23.13 came falling about -4.62 while comparing to the previous closing price of $24.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $26.41 and as low as $6.52. In the recent trading on the day, stock has struck highest price mark of $23.0 while lowest mark touched by it was $24.27.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Goldman which upgraded the stock as “Neutral” in its note to investors issued on August 02, 2023, recommending a price target of between $16 and $12 for it. BofA Securities issued its recommendations for the stock as it initiated the price target for the stock is $5.
Over the week, TGTX’s stock price is moving -5.59% down while it is -0.77% when we observe its performance for the past one month. Year-to-date it is 35.42% up and over the past year, the stock is showing an upside performance of 245.74%.
Currently, TG Therapeutics Inc’s total number of outstanding shares is 151.42M. Company’s return on investment (ROI) stands at 33.13% and return on equity (ROE) at 87.78%. It has a price to earnings ratio (P/E ratio) of 38.54 while having a 31.11 of forward P/E ratio. Stock’s beta reads 2.20. Stock has a price to book (P/B) ratio of 20.17 while price to sale or P/S ratio amounts to 10.33. Its return on asset (ROA) is 30.76% on average.
